BridgeBio Pharma, Inc. (BBIO)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch BBIO
See up to 3 months of BBIO. The 7-day demo opens the 1M and 3M ranges and puts BBIO on your watchlist.
Start 7-day demoLatest BBIO insider trades
About BridgeBio Pharma, Inc. (BBIO)
BridgeBio Pharma, Inc. is an SEC registrant, filing under CIK 0001743881, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
BBIO Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 10 | 56,980 | $4.58M |
| Option exercise | 8 | 142,434 | |
| Tax withholding / forfeiture | 3 | 63,732 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BBIO insider transactions (Form 4)
7794 Form 4 filings on record, the earliest from Nov 19, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Frank McCormick - Director | Option exercise | Common Stock | 74,000 | $11.92 | $882K | |
| Frank McCormick - Director | Open-market sale | Common Stock | 74,000 | $53.16 | $3.93M | |
| Frank McCormick - Director | Option exercise | Stock Option (Right to Buy) | 74,000 | $0.00 | - | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 14,525 | $51.15 | $743K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 5,475 | $51.85 | $284K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 2,300 | $51.95 | $119K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 16,800 | $53.16 | $893K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 900 | $53.80 | $48K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 14,558 | $51.16 | $745K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 5,442 | $51.85 | $282K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 2,300 | $51.96 | $120K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 16,900 | $53.16 | $898K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 800 | $53.80 | $43K | |
| Thomas Trimarchi - Officer | Open-market sale | Common Stock | 42,237 | $49.48 | $2.09M | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 25,728 | $48.81 | $1.26M | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 428 | $49.25 | $21K | |
| Maricel Apuli - Officer | Tax withholding / forfeiture | Common Stock | 4,781 | $51.32 | $245K | |
| Thomas Trimarchi - Officer | Tax withholding / forfeiture | Common Stock | 21,317 | $51.32 | $1.09M | |
| Thomas Trimarchi - Officer | Open-market sale | Common Stock | 15,380 | $50.14 | $771K | |
| Thomas Trimarchi - Officer | Open-market sale | Common Stock | 1,973 | $50.94 | $101K | |
| Neil Kumar - Officer | Option exercise | Common Stock | 64,697 | - | - | |
| Neil Kumar - Officer | Tax withholding / forfeiture | Common Stock | 32,855 | $51.32 | $1.69M | |
| Neil Kumar - Officer | Option exercise | Restricted Stock Units | 33,544 | $0.00 | - | |
| Neil Kumar - Officer | Option exercise | Restricted Stock Units | 19,599 | $0.00 | - | |
| Neil Kumar - Officer | Option exercise | Restricted Stock Units | 11,554 | $0.00 | - | |
| Charles J. Homcy | Open-market sale | Common Stock | 191,662 | $45.87 | $8.79M | |
| Charles J. Homcy | Open-market sale | Common Stock | 58,338 | $46.64 | $2.72M | |
| Charles J. Homcy | Open-market sale | Common Stock | 50,000 | $48.00 | $2.40M | |
| Maricel Apuli - Officer | Open-market sale | Common Stock | 1,000 | $45.44 | $45K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 6,784 | $45.09 | $306K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 13,216 | $45.64 | $603K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 11,795 | $45.88 | $541K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 8,205 | $46.71 | $383K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 6,784 | $45.09 | $306K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 13,216 | $45.64 | $603K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 11,795 | $45.88 | $541K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 8,205 | $46.71 | $383K | |
| Andrea Ellis | Option exercise | Common Stock | 17,167 | $16.75 | $288K | |
| Andrea Ellis | Open-market sale | Common Stock | 17,167 | $49.00 | $841K | |
| Andrea Ellis | Option exercise | Stock Option (right to buy) | 17,167 | $0.00 | - | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 18,300 | $42.50 | $778K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 1,700 | $42.88 | $73K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 20,000 | $42.73 | $855K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 18,400 | $42.51 | $782K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 1,600 | $42.89 | $69K | |
| Neil Kumar - Officer | Open-market sale | Common Stock | 20,000 | $42.73 | $855K | |
| Charles J. Homcy | Gift | Common Stock | 20,000 | $0.00 | - | |
| VIKING GLOBAL INVESTORS LP | Open-market sale | Common Stock | 3,500,000 | $44.00 | $154.00M | |
| Frank McCormick | Open-market sale | Common Stock | 100,000 | $44.23 | $4.42M | |
| Eric Aguiar | Grant or award | Common Stock | 6,589 | $0.00 | - | |
| Eric Aguiar | Grant or award | Stock Option (Right to Buy) | 8,425 | $0.00 | - | |
| Frank McCormick | Grant or award | Common Stock | 6,589 | $0.00 | - | |
| Frank McCormick | Grant or award | Stock Option (Right to Buy) | 8,425 | $0.00 | - | |
| James C. Momtazee | Grant or award | Common Stock | 6,589 | $0.00 | - | |
| James C. Momtazee | Grant or award | Stock Option (Right to Buy) | 8,425 | $0.00 | - | |
| Charles J. Homcy | Grant or award | Common Stock | 6,589 | $0.00 | - | |
| Charles J. Homcy | Grant or award | Stock Option (Right to Buy) | 8,425 | $0.00 | - | |
| Ronald J. Daniels | Grant or award | Common Stock | 6,589 | $0.00 | - | |
| Ronald J. Daniels | Grant or award | Stock Option (Right to Buy) | 8,425 | $0.00 | - | |
 Fred Hassan | Grant or award | Common Stock | 6,589 | $0.00 | - | |
| Fred Hassan | Grant or award | Stock Option (Right to Buy) | 8,425 | $0.00 | - | |
| KKR Genetic Disorder L.P. | Open-market sale | Common Stock | 6,000,000 | $34.20 | $205.20M | |
| Frank McCormick | Gift | Common Stock | 33,000 | $0.00 | - | |
| Frank McCormick | Gift | Common Stock | 3,000 | $0.00 | - | |
| Ali J. Satvat | Option exercise | Common Stock | 79,702 | $10.99 | $876K | |
| Ali J. Satvat | Option exercise | Common Stock | 39,851 | $16.68 | $665K | |
| Ali J. Satvat | Option exercise | Common Stock | 39,851 | $26.21 | $1.04M | |
| Ali J. Satvat | Option exercise | Stock Option (Right to Buy) | 79,702 | $0.00 | - | |
| Ali J. Satvat | Option exercise | Stock Option (Right to Buy) | 39,851 | $0.00 | - | |
| Ali J. Satvat | Option exercise | Stock Option (Right to Buy) | 39,851 | $0.00 | - | |
| Neil Kumar - Officer | Gift | Common Stock | 4,685,725 | $0.00 | - | |
| Neil Kumar - Officer | Gift | Common Stock | 4,685,725 | $0.00 | - | |
| Frank McCormick | Gift | Common Stock | 7,400 | $0.00 | - | |
| Brian C. Stephenson - Officer | Grant or award | Restricted Stock Units | 42,683 | $0.00 | - | |
| Thomas Trimarchi - Officer | Grant or award | Common Stock | 50,000 | $0.00 | - | |
| Neil Kumar - Officer | Grant or award | Restricted Stock Units | 121,951 | $0.00 | - | |
| Brian C. Stephenson - Officer | Open-market sale | Common Stock | 4,156 | $22.41 | $93K |
See every BBIO filing on record
These pages show the latest 90 of 94 Form 4 filings on record. The 7-day demo shows all 94, and sign-up brings you back to this table.
Item 8.01, 9.01
Item 8.01, 9.01
Item 1.01, 8.01, 9.01
Item 2.02, 9.01
Recent BBIO Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| KUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019 | Director, Officer | 30,000 | $2.49M | View on EDGAR | |
| NEIL KUMAR | Director, Officer | 34,980 |
Stock trades in BBIO disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Sale (partial) |
BBIO insider trading FAQ
What is the latest insider trade for BBIO?
BridgeBio Pharma, Inc. (BBIO) had 6 insider filings in the last 90 days, with the most recent on 2026-09-21. The full record for BBIO runs to 94 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BBIO stock?
No insider purchases of BBIO were filed in the last 90 days.
How many insiders are selling BBIO stock?
10 insider sales of BBIO were filed in the last 90 days, totaling $4.58M.
Where can I see BBIO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BBIO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Neil Kumar view on EDGAR
- - Neil Kumar view on EDGAR
- - Thomas Trimarchi view on EDGAR
- - Neil Kumar view on EDGAR
- - Maricel Apuli view on EDGAR
- - Maricel Apuli view on EDGAR
- - Andrea Ellis view on EDGAR
- - Jennifer E. Cook view on EDGAR
- - Jennifer E. Cook view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where BBIO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BBIO with a 7-day demo
- BBIO on your watchlist
- Every BBIO Form 4 filing on record
- Up to 3 months of BBIO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
